Lebret T - Search Results

1

Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.

Lebret T, Watson RW, Molinié V, O'Neill A, Gabriel C, Fitzpatrick JM, Botto H. Lebret T, et al. Cancer. 2003 Sep 1;98(5):970-7. doi: 10.1002/cncr.11594. Cancer. 2003. PMID: 12942564 Free article.

2

No evidence of metabolic disorders 10 to 22 years after Camey type I ileal enterocystoplasty.

Salomon L, Lugagne PM, Herve JM, Barre P, Lebret T, Botto H. Salomon L, et al. Among authors: lebret t. J Urol. 1997 Jun;157(6):2104-6. J Urol. 1997. PMID: 9146590

3

Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer.

Lebret T, Becette V, Barbagelatta M, Hervé JM, Gaudez F, Barré P, Lugagne PM, Botto H. Lebret T, et al. J Urol. 1998 Mar;159(3):788-91. J Urol. 1998. PMID: 9474149

4

Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy.

Lebret T, Hervé JM, Barré P, Gaudez F, Lugagne PM, Barbagelatta M, Botto H. Lebret T, et al. Eur Urol. 1998;33(2):170-4. doi: 10.1159/000019550. Eur Urol. 1998. PMID: 9519359

5

[The absence of metabolic disorders 8 years after detubulized Z entero-cystoplasty].

Salomon L, Lugagne PM, Hervé JM, Barre P, Lebret T, Botto H. Salomon L, et al. Among authors: lebret t. Prog Urol. 1998 Feb;8(1):62-7. Prog Urol. 1998. PMID: 9533154 French.

6

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.

Lebret T, Gaudez F, Hervé JM, Barré P, Lugagne PM, Botto H. Lebret T, et al. Eur Urol. 1998;34(1):67-72. doi: 10.1159/000019664. Eur Urol. 1998. PMID: 9676417

7

[Study of the Ki-67 antibody immunolabeling of renal adenocarcinomas with or without renal vein thrombosis].

Lebret T, Becette V, Colau A, Hervé JM, Molinié V, Barré P, Lugagne-Delpon PM, Gentile A, Baglin C, Botto H. Lebret T, et al. Prog Urol. 1999 Sep;9(4):649-54. Prog Urol. 1999. PMID: 10555216 French.

8

Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.

Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H. Lebret T, et al. J Urol. 2000 Jan;163(1):63-7. J Urol. 2000. PMID: 10604315 Clinical Trial.

9

Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer.

Lebret T, Becette V, Hervé JM, Molinié V, Barré P, Lugagne PM, Gentille A, Baglin AC, Botto H. Lebret T, et al. Eur Urol. 2000 Jun;37(6):654-9. doi: 10.1159/000020233. Eur Urol. 2000. PMID: 10828663

10

[Study of survival after cystectomy for bladder cancer. Report of 504 cases].

Lebret T, Hervé JM, Yonneau L, Barré P, Lugagne PM, Butreau M, Molinié V, Botto H. Lebret T, et al. Prog Urol. 2000 Sep;10(4):553-60. Prog Urol. 2000. PMID: 11064896 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results